Full-Time

Senior Specialist

Patient Safety

Confirmed live in the last 24 hours

AstraZeneca

AstraZeneca

10,001+ employees

Develops and commercializes prescription medicines

No salary listed

Senior

Dublin, Ireland

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Google Cloud Platform
Requirements
  • Understanding of local UK, Ireland and Malta health authority regulations
  • Experience in internal audits / external health authority inspections
  • Experience in using Pharmacovigilance systems such as Argus and Veeva Vault modules
  • Experience in Pharmacovigilance vendor management
  • Excellent attention to detail, project management, problem solving, written and communication, and change management skills
  • Strong data analytics abilities
Responsibilities
  • Managing day-to-day Pharmacovigilance operations via management of Pharmacovigilance activities, databases, projects, procedures and services in line with local health authority regulations
  • Embedding yourself with other GxP stakeholders such as GRP and GCP, forming an enterprise to maintain upmost compliance
  • Ensuring cross-function collaboration through sharing Patient Safety knowledge and training with the local marketing company teams (e.g., Marketing, Sales, Regulatory Affairs, Medical Affairs)
  • Providing technical guidance and contribution to local and global projects aligned to or involving Patient Safety
  • Facilitating the necessary quality requirements, including the provision and submission of Pharmacovigilance data to Global Patient Safety and local health authorities
  • Ensuring timely submission of ICSR, follow-up cases, and other safety documents (PBRERs, DSURs, Signals, SUSARs, RMPs, DHPCs, etc) to local health authorities
  • Acting per local legislation requirements as a deputy Patient Safety Contact Point/LRPPV (or deputy) with the local health authority to manage Individual Case Safety Report (ICSR) related queries, AstraZeneca and Alexion product-related safety concerns, or activities related to Risk Management Plans (RMPs).
Desired Qualifications
  • Knowledge of and experience in local Marketing Companies including established cross-functional stakeholder relationships
  • Medical knowledge in AstraZeneca and Alexion business units and therapy areas
  • Leadership skills
  • Proven track record on above-market Patient Safety projects

AstraZeneca focuses on discovering, developing, and selling prescription medicines. The company specializes in three main areas: Oncology, which deals with cancer treatment; Cardiovascular, Renal & Metabolism, which addresses heart, kidney, and metabolic diseases; and Respiratory & Immunology, which targets lung and immune system diseases. Their products are developed through extensive research and development, followed by clinical trials and regulatory approvals before reaching the market. AstraZeneca stands out from competitors by investing heavily in scientific research and fostering collaborations through initiatives like their Open Innovation program, which shares resources with the scientific community to speed up drug discovery. Their goal is to advance healthcare by creating effective treatments for serious diseases and expanding their product offerings through strategic partnerships.

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery enhances AstraZeneca's R&D efficiency.
  • Real-world evidence supports AstraZeneca's drug efficacy and safety demonstrations.
  • Personalized medicine complements AstraZeneca's focus on targeted therapies.

What critics are saying

  • AI tool for breast cancer screening may face effectiveness challenges.
  • Investment in Dunkirk may be affected by changes in French investment regulations.
  • Highly competitive pharmaceutical market requires constant innovation and regulatory compliance.

What makes AstraZeneca unique

  • AstraZeneca excels in Oncology, Cardiovascular, and Respiratory therapy areas.
  • The A.Catalyst Network fosters global collaboration and innovation in healthcare.
  • Open Innovation program accelerates drug discovery by sharing resources with the scientific community.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

Our Health Needs
Apr 11th, 2025
Study: Racial, ethnic minorities are underrepresented in AI mammogram interpretation

In 2024, AI biotech company Owkin partnered with pharma giant AstraZeneca to develop an AI-powered tool designed to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides.

Medical Update Online
Apr 11th, 2025
AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025

AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025.

Cision
Apr 11th, 2025
Result Of Agm

11 April 2025Results of Annual General Meeting held on 11 April 2025AstraZeneca PLC announced the results of the voting at its Annual General Meeting (AGM) today. As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 9 - 12 were passed as special resolutions; all other resolutions were passed as ordinary resolutions.Resolution. Votes for. % of votes cast

Europawire
Apr 8th, 2025
AstraZeneca Unveils Breakthrough Data on Vaccines and Antibody Therapies for Infections

AstraZeneca unveils breakthrough data on vaccines and antibody therapies for infections.

Delcade
Apr 4th, 2025
Foreign investment in France: Key trends, legal considerations (2024)

AstraZeneca invested €365 million in expanding its production lines in Dunkirk.